Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

434
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
434
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.2K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive Health Technology Assessment - value and limitations to inform resource allocation in India.

Health economics, policy, and law·2026
Same author

Qualitative research - Part 1.

Perspectives in clinical research·2026
Same author

Patient and public involvement in cancer care and research: the Indian perspective.

Ecancermedicalscience·2026
Same author

Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.

Current problems in cancer·2026
Same author

Addressing low-value care (LVC) in Asia: a narrative review of Choosing Wisely and other initiatives across Asia.

BMJ open quality·2026
Same author

Robotic Ivor Lewis oesophagectomy with intrathoracic hybrid anastomosis.

Multimedia manual of cardiothoracic surgery : MMCTS·2026
Same journal

Cortical and brainstem mechanisms of pain: linking defensive responses, descending modulation, and affective-sensory integration.

Current opinion in supportive and palliative care·2026
Same journal

Comparison of the EORTC QLQ-EN24, FACT-En, and FEnSI-23 for assessing quality of life in endometrial cancer: a systematic review.

Current opinion in supportive and palliative care·2026
Same journal

Dysphagia, aspiration, and respiratory problems in people with chronic respiratory illness.

Current opinion in supportive and palliative care·2026
Same journal

Decision-making and treatment planning for older adults with pre-existing cognitive impairment and cancer.

Current opinion in supportive and palliative care·2026
Same journal

Clinical decision support system for breathlessness.

Current opinion in supportive and palliative care·2026
Same journal

The prevalence of persisting breathlessness despite treatment in chronic conditions.

Current opinion in supportive and palliative care·2026
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

Virtual oncology research-different models and lessons learned.

P Ranganathan1, C S Pramesh2

  • 1Department of Anaesthesiology, Critical Care and Pain.

Current Opinion in Supportive and Palliative Care
|August 5, 2022
PubMed
Summary
This summary is machine-generated.

The COVID-19 pandemic disrupted cancer research, but innovative adaptations like virtual trials improved efficiency and patient access. These changes offer lasting benefits for clinical research beyond the pandemic.

More Related Videos

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

1.8K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.7K

Related Experiment Videos

Last Updated: Sep 2, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

1.8K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.7K

Area of Science:

  • Oncology
  • Clinical Research
  • Epidemiology

Background:

  • The COVID-19 pandemic significantly challenged cancer research operations globally.
  • Disruptions included trial halts, reduced patient recruitment, and protocol deviations due to rigid clinical trial processes.

Purpose of the Study:

  • To review innovative adaptations implemented in cancer research during the COVID-19 pandemic.
  • To assess the feasibility and potential long-term application of these adaptations post-pandemic.

Main Methods:

  • Review of adaptations in clinical trial processes necessitated by the pandemic.
  • Increased adoption of digital technologies and virtual trial components.
  • Modifications in ethics, regulatory approvals, patient consenting, and trial monitoring.

Main Results:

  • Successful implementation of virtual clinical trials with protocol amendments.
  • Demonstrated safety and feasibility of adaptations without compromising data integrity.
  • Benefits include enhanced patient diversity, reduced patient burden, and resource optimization.

Conclusions:

  • Pandemic-induced adaptations in cancer research are largely safe and effective.
  • Learnings from the pandemic can enhance the efficiency and accessibility of clinical research.
  • Many adaptations are likely to persist beyond the pandemic, improving future research practices.